FDA Accepted Flu Vaccine From Using Animal

The hygienic Food and Drug management says it has accepted the primary seasonal flu vaccine made using animal body cell technology, slightly than the half-century egg process method. The FDA approved Novartis' Flucelvax to prevent infection in people 18 years and older.

The new method system has been promoted by U.S. health officials because it is faster than egg-based making and could speed up developed in the occasion of a pandemic. In the older way, virus samples are injected into dedicated chicken eggs and incubated. The egg fluids are afterward harvested, intense and purified into the vaccine. With cell technology, little amounts of virus are put in fermenting tanks with nutrients and cells resulting from mammals. The virus is then inactivated, purify and put into vaccine vials.

Immunizations keep lives

April 23 to 30 is National Infant Immunization week. National Infant Immunization week is an annual observance promote by the Centers for Disease Control and Prevention to highlight the significance of protecting infants from vaccine-preventable diseases. Through immunization, we can now keep infants and children from 14 vaccine-preventable diseases before the age of 2. Unfortunately, more than 100,000 children across the world exterior of the United States die from measles every year. In the United States, there were 42 cases of measles between January and April. Dangerous infections such as poliovirus and haemophilus influenzae have been brought under control since of the immunization of vulnerable infant early in life.

Although immunization in our country has been very successful, that success depends on reliable vigilance on the part of parents and health care providers. Parents need to be aware of immunization agenda and the advantages of immunization to their infants. When the system for immunizing young children in our country breaks down, there are grave penalty. In California during 2010, there was an outbreak of a vaccine-avoidable disease called whooping cough. There were 8,000 infections and 10 infant deaths. The cause of the outbreak was a population of children who did not get proper immunization.

Adolescent and adult vaccination with Tdap boosters also will help avoid adult disease which will decrease the spread of this deadly disease to infants. The information is that the vaccines given to children younger than 2 years in this country are very safe. The vaccines are thoroughly tested before being accepted for public use and are carefully monitored by doctors, researchers, and public health officials. Numerous studies have exposed that there is no link between vaccines and autism. There is no question vaccines make our country healthier and keep our youngest children. If you have questions about what vaccines your child should get, talk to your pediatrician.

Secondhand Smoke can put Kids at Risk for Diseases

Exposure to secondhand smoke greatly enlarge a child's chances of developing several invasive bacterial diseases, according to a new appraisal of published studies. The risk was found to be particularly strong for children 6 years old and younger. Exposure to secondhand smoke double the risk for enveloping meningococcal disease, the analysis found, and may also enlarge the chances of developing invasive pneumococcal disease and Haemophilus influenza type B. The result, which came from an analysis of 42 studies, most conduct in high income countries with good immunization policies, are published online in PLoS Medicine.

The results suggest that decreasing children's experience to secondhand smoke could decrease the number of illness and deaths caused by these diseases, particularly in poor countries with low rates of vaccination against enveloping bacterial diseases, according to study author Chien Chang Lee of the Harvard School of Public Health and fellow researchers. "Because the burden of invasive bacterial disease is top in developing countries where secondhand smoke is rising, there is a need for high quality studies to prove these results and for interventions to decrease exposure of children to secondhand smoke," they said in a journal news release.

useful links : transport rankings 

Vaccine to hit disease in 25 African nations

Epidemics of bacterial meningitis have swept across Africa for more than a century, inward with the dry harmattan winds to kill with terrifying speed. But today a drive starts to inoculate tens of millions of West Africans with a latest vaccine in what scientists hope will be the beginning of the end of ravaging meningitis epidemics. The aim is for immunization to extend, from Senegal in the west to Ethiopia in the east, and bring the disease under control in a belt of 25 nations that girds the continent, saving an predictable 150,000 lives by 2015.

Hundreds of millions more dollars are still wanted to accomplish that goal, but the meningitis vaccine itself is a milestone in developing cheap vaccines against neglected diseases that afflict poor countries, experts say. More than 1 million cases of meningitis have been report in Africa over the past two decades. The vaccine works beside the group a meningitis strain that cause more than eight out of 10 cases on the continent. Bill Gates, whose foundation mainly financed the Endeavour, contrasted the undertaking with the growth of vaccines for measles, smallpox and polio.

''All those things were shaped because rich people got sick,'' he said. ''This is the first vaccine that goes through the entire process where there was no rich world market, and it had to be optimized at a very low price.'' The meningitis vaccination drives begin today in Burkina Faso and will also obtain under way in Mali and Niger this month. So far, donors and African countries have raise $US95 million of the estimated $US570 million cost, World Health Organization officials say. But the global financial disaster has pinched foreign aid spending, departure the remainder in doubt.

useful links : transport rankings  

Treating dengue more hard with growing obesity: experts

Dengue patients suffer from capillary permeability, when fluid escape from their blood vessels into surrounding tissues, causing breathing complexity and complications in major organs like the brain, liver and kidneys. "The virus has a crash on the wall of the capillaries and allow more fluids to go away the tubes and into the tissues," said Jeremy Farrar, tropical medicine professor and director of the Oxford University Clinical Research Unit in Vietnam. "The complication is lots of fluids in the lungs which create breathing difficult.

In people who have a high BMI (body mass index), their capillaries are essentially more likely to leak, so that is made worse in a dengue infection," Farrar told Reuters after addressing a communicable disease conference in Singapore. Dengue used to be a disease mainly among young children, but almost anyone is now vulnerable and infection numbers have shot up because of urbanization and the steady movement of people circumstances that allow the Aedes aegypti mosquito, which carries the virus, to thrive.

The World Health Organization estimate there is 50 million dengue infection worldwide each year. Among these are 500,000 harsh cases what is known as dengue haemorrhagic fever (DHF). There are about 22,000 deaths yearly, mainly among children. Dengue is expensive, costing an average of US$1,394 for each hospitalized patient. At least 10 working days are lost in each case. About 2.5 billion people live in more than 100 endemic countries and area where dengue viruses can be transmit. There is now no cure or vaccine for dengue, although Sanofi Aventis SA has an applicant vaccine in the final stage of clinical development.

useful links : transport rankings  

CDC Report find Adult Vaccination Rates Still Lagging

Although there have been slight increase in some adult vaccination rates, U.S. health officials report Wednesday that those rates are still not what they should be. "We wanted vaccinations as infants and toddlers, but we also require vaccinations as adults," Dr. Susan J. Rehm, medical director of the National Foundation for Infectious Diseases, said during an afternoon news conference Wednesday. Rehm noted that vaccination rates among children are very good. "Because of that, we observe only a fraction of the vaccine avoidable diseases we saw in the past, and a part of the deaths and sufferings from these diseases," she said. "But our advance will be undone if we do not keep our immunity as adults."

Speaking at the similar news conference, Dr. Melinda Wharton, deputy director of the National Center for vaccination and Respiratory Diseases at the U.S. Centers for Disease Control and avoidance, announce some new data on adult immunization rates. The rate of reporting for the pneumococcal vaccine, which is advocate for adults over the age of 65 to prevent pneumonia, has remain at 65 percent since 2008, Wharton said. However, the rate of vaccination among blacks and Hispanics is far under this, she added.

The rate of adults being vaccinated with the newer vaccines is rising, Wharton said. The human papillomavirus (HPV) vaccine was first recommended in 2007 for young women to avoid cervical cancer. By 2009, 17 percent of women aged 19 to 26 had conventional at least one shot three are necessary, Wharton noted. "This is up 6.2 percent, compare with 2008," she said. Another new vaccine is the herpes zoster vaccine, which prevent shingles and is optional for adults aged 60 and over. Coverage with this vaccine is up a small from 2008, from 8 percent to 10 percent, Wharton said.

American and the Flu Vaccine

Almost all physicians plan to get vaccinated beside influenza this season and most also discuss the vaccine with patients. However, more than 40 percent of Americans in common do not plan to get vaccinate this season, many of whom have misconceptions about the vaccine or the disease, according to survey fallout announce by the U.S. Centers for Disease Control and Prevention and the National Foundation for Infectious Diseases (NFID) at an Oct. 7 news conference. The survey results exposed that more than two-thirds of Americans are aware of the new universal influenza vaccination recommendation.

Fifty-seven percent of Americans plan to be vaccinating this influenza season, with adults 65 years and older having the top intent to vaccinate and adults 45 to 54 years of age having the lowest intent to vaccinate. Of those individuals who do not plan on receiving vaccinated, misconceptions and "magical thinking" represent the key reasons, according to the CDC. The survey findings also exposed that 65 percent of mothers point out a positive intent to have children vaccinated this season but that 33 percent are unlikely to vaccinate their children. In addition, 95 percent of physicians have been or intend to obtain vaccinated this season, 96 percent of doctors advocate influenza vaccination to their family and friends, and 92 percent discuss the vaccine with their patients.

"Patients rely on the doctors as role models for influenza vaccination. Now we require to get other health care professionals to move in this same direction to all nurses, physician assistants, nurse practitioners, pharmacists and others please, get vaccinated and advocate the vaccine to your patients," president of NFID, William Schaffner, M.D., of the Vanderbilt University School of Medicine in Memphis, Tenn., said in a statement. The news conference was supported in part through unobstructed educational grants to NFID from Genentech, GlaxoSmithKline, MedImmune, Merck and Co. Inc., Novartis Vaccine, Pfizer Inc., Sanofi Pasteur, and Walgreens.

useful links : transport rankings